Cargando…
PEN Receptor GPR83 in Anxiety-Like Behaviors: Differential Regulation in Global vs Amygdalar Knockdown
Anxiety disorders are prevalent across the United States and result in a large personal and societal burden. Currently, numerous therapeutic and pharmaceutical treatment options exist. However, drugs to classical receptor targets have shown limited efficacy and often come with unpleasant side effect...
Autores principales: | Fakira, Amanda K., Lueptow, Lindsay M., Trimbake, Nikita A., Devi, Lakshmi A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427670/ https://www.ncbi.nlm.nih.gov/pubmed/34512237 http://dx.doi.org/10.3389/fnins.2021.675769 |
Ejemplares similares
-
Is the Neuropeptide PEN a Ligand of GPR83?
por: Giesecke, Yvonne, et al.
Publicado: (2023) -
The Contribution of the Descending Pain Modulatory Pathway in Opioid Tolerance
por: Lueptow, Lindsay M., et al.
Publicado: (2018) -
Increased Amygdalar and Hippocampal Volumes in Young Adults with Social Anxiety
por: Machado-de-Sousa, João Paulo, et al.
Publicado: (2014) -
Evolutionarily-conserved prefrontal-amygdalar dysfunction in early-life anxiety
por: Birn, Rasmus M., et al.
Publicado: (2014) -
Amygdalar Endothelin-1 Regulates Pyramidal Neuron Excitability and Affects Anxiety
por: Chen, Ming, et al.
Publicado: (2017)